Short Interest in Ainos, Inc. (NASDAQ:AIMD) Rises By 69.5%

Ainos, Inc. (NASDAQ:AIMD) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 402,500 shares, an increase of 69.5% from the February 28th total of 237,400 shares. Currently, 12.0% of the shares of the company are short sold. Based on an average daily volume of 637,300 shares, the short-interest ratio is presently 0.6 days.

Ainos Stock Performance

Shares of NASDAQ AIMD opened at $0.51 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.37 and a quick ratio of 1.33. The firm has a market cap of $7.87 million, a price-to-earnings ratio of -0.31 and a beta of 1.51. The stock’s fifty day moving average price is $0.60 and its two-hundred day moving average price is $0.53. Ainos has a one year low of $0.40 and a one year high of $1.46.

Ainos (NASDAQ:AIMD) last released its quarterly earnings results on Friday, March 7th. The company reported ($0.26) EPS for the quarter.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.